Dr. Cohen and colleagues’ study was funded by the Municipal Health Authority and Marcia Maria Braido Hospital in São Paulo, Brazil. Dr. Cohen disclosed that he received previous study funding from Covidien, and one of his coauthors, Dr. David E. Cummings of the University of Washington, Seattle, disclosed receiving past funding from Ethicon Endo-Surgery. The other authors said they had no relevant financial disclosures.
FROM DIABETES CARE
Next Article:
More Obesity News
- Liquid Fasting Mitigates Negative Pre-Surgery Impact of Semaglutide
- GLP-1 RAs Safe in the Perioperative Period: New Guidance
- Coming Soon: A New Disease Definition, ‘Clinical Obesity’
- Can We Repurpose Obesity Drugs to Reverse Liver Disease?
- Weight Loss Surgery, Obesity Drugs Achieve Similar Results but Have Different Safety Profiles
- Will New Obesity Drugs Make Bariatric Surgery Obsolete?
- Time-Restricted Eating Fails for Weight Loss and Glucose Homeostasis
- A New Era of Obesity Medicine
Gastrointestinal involvement in lupus
Question 1 of 4